view video
Announcing the SUFU Visiting Professorship
This 1-day visiting professorship will be offered to interested training programs and will consist of a lecture series from a member of the SUFU Executive Committee encompassing all aspects of FPMRS, Urodynamics, and Neurourology. read more »
SUFU Statement Regarding FDA Communication on “Vaginal Rejuvenation”
read more »
Overactive Bladder Clinical (OAB) Care Pathway
SUFU is providing the Overactive Bladder Clinical Care Pathway for use by providers and patients. Overactive Bladder CCP Provider Flowchart »Overactive Bladder CCP Patient Roadmap » read more »
Grant Opportunities
read more »

Fellowships

Accredited | Non-Accredited
Updates & Announcements

Guidelines

AUA/SUFU Guidelines

Grant
Opportunities

NAU Online Journal

Donate

Donate to the
SUFU Research Foundation
News & Announcements
  • SUFU Update on FDA meeting On February 12th 2019, the FDA convened a meeting of the Obstetrics and Gynecology Medical Device Advisory Committee in Washington, D.C. to specifically address the safety and effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse in the anterior vaginal compartment. ... [read more]
  • UPDATED: SUFU MUS Position Statement SUFU Position Statement on Mesh Midurethral Slings (MUS) for Stress Urinary Incontinence (Updated February 2019)... [read more]

View All

Neurourology and Urodynamics

Editorial, Volume 38(3)
Tuesday, March 19, 2019
Randomized, open‐label, tolterodine‐controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder
Tuesday, March 19, 2019
Read More
Industry News
Affiliate Organizations
Find a Urologist
Follow SUFU